Talpaz, M., & Kiladjian, J. (2020). Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis. Leukemia.
استشهاد بنمط شيكاغوTalpaz, Moshe, و Jean-Jacques Kiladjian. "Fedratinib, a Newly Approved Treatment for Patients With Myeloproliferative Neoplasm-associated Myelofibrosis." Leukemia 2020.
MLA استشهادTalpaz, Moshe, و Jean-Jacques Kiladjian. "Fedratinib, a Newly Approved Treatment for Patients With Myeloproliferative Neoplasm-associated Myelofibrosis." Leukemia 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.